Enanta Pharmaceuticals, Inc.
ENTA
Health Care
1
exclusion reason
1 theme
This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. But it is subject to change as our understanding of the facts evolves.
Enanta Pharmaceuticals is a biotechnology company whose core business model involves animal testing as a standard component of drug development. The company's preclinical research activities, as disclosed in its regulatory filings, require the completion of laboratory tests and animal studies conducted according to Good Laboratory Practice (GLP) standards. This reliance on animal models is integral to the development of its therapeutic candidates.
While the provided evidence does not detail specific testing protocols or species used, the company's operations fall under the broad exclusion for commercial animal exploitation. This category captures activities where animals are used as a means to commercial ends, which includes the pharmaceutical industry's widespread use of animals in preclinical research and toxicity testing.
Research Sources
1 organization
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.